Publikationen von A. Yassouridis

Schuld, A.; Uhr, M.; Yassouridis, A.; Pollmächer, T.: Influence of sleep deprivation on plasma ghrelin levels in healthy subjects. Pharmacopsychiatry 36 (5), S. 264 - 264 (2003)

Otte, C.; Jahn, H.; Yassouridis, A.; Arlt, J.; Stober, N.; Maass, P.; Wiedemann, K.; Kellner, M.: The mineralocorticoid receptor agonist, fludrocortisone, inhibits pituitary-adrenal activity in humans after pre-treatment with metyrapone. Life Sciences 73 (14), S. 1835 - 1845 (2003)

Cota, D.; Marsicano, G.; Tschop, M.; Grübler, Y.; Flachskamm, C.; Schubert, M.; Auer, D.; Yassouridis, A.; Thone-Reineke, C.; Ortmann, S. et al.; Tomassoni, F.; Cervino, C.; Nisoli, E.; Linthorst, A. C. E.; Pasquali, R.; Lutz, B.; Stalla, G. K.; Pagotto, U.: The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. Journal of Clinical Investigation 112 (3), S. 423 - 431 (2003)

Herr, A. S.; Tsolakidou, A. F.; Yassouridis, A.; Holsboer, F.; Rein, T.: Antidepressants differentially influence the transcriptional activity of the glucocorticoid receptor in vitro. Neuroendocrinology 78 (1), S. 12 - 22 (2003)

Kellner, M.; Baker, D. G.; Yassouridis, A.; Otte, C.; Wiedemann, K.: Mineralocorticoid receptor antagonism in patients with post-traumatic stress disorder: Effects on basal and stimulated cortisol secretion. Biological Psychiatry 53 (8 Suppl.1), S. 150S - 150S (2003)

Kellner, M.; Yassouridis, A.; Hua, Y.; Jahn, H.; Wiedemann, K.: C-type natriuretic peptide augments anxiogenic and endocrine effects of cholecystokinin-tetrapeptide in man. Biological Psychiatry 53 (8 Suppl. 1), S. 199S - 199S (2003)

Otte, C.; Wiedemann, K.; Yassouridis, A.; Maass, P.; Stober, N.; Kellner, M.: Hippocampal mineralocorticoid receptors inhibit the hypothalamus-pituitary-adrenal axis: A new metyrapone-fludrocortisone test and effect of age. Biological Psychiatry 53 (8 Suppl.), S. 89S - 90S (2003)

Nickel, T.; Sonntag, A.; Schill, J.; Zobel, A. W.; Ackl, N.; Brunnauer, A.; Murck, H.; Ising, M.; Yassouridis, A.; Steiger, A. et al.; Zihl, J.; Holsboer, F.: Clinical and neurobiological effects of tianeptine and paroxetine in major depression. Journal of Clinical Psychopharmacology 23 (2), S. 155 - 168 (2003)

Frieboes, R.-M.; Sonntag, A.; Yassouridis, A.; Eap, C. B.; Baumann, P.; Steiger, A.: Clinical outcome after trimipramine in patients with delusional depression - a pilot study. Pharmacopsychiatry 36, S. 12 - 17 (2003)

Kellner, M.; Yassouridis, A.; Hübner, R.; Baker, D. G.; Wiedemann, K.: Endocrine and cardiovascular responses to corticotropin-releasing hormone in patients with posttraumatic stress disorder: A role for atrial natriuretic peptide? Neuropsychobiology 47 (2), S. 102 - 108 (2003)

Farina, C.; Then Bergh, F.; Albrecht, H.; Meinl, E.; Yassouridis, A.; Neuhaus, O.; Hohlfeld, R.: Treatment of multiple sclerosis with Copaxone (COP). Elispot assay detects COP-induced interleukin-4 and interferon-γ response in blood cells. Brain 124, S. 705 - 719 (2001)

Müller, M. B.; Lucassen, P. J.; Yassouridis, A.; Hoogendijk, W. J. G.; Holsboer, F.; Swaab, D. F.: Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus. European Journal of Neuroscience 14, S. 1603 - 1612 (2001)

Wiedemann, K.; Jahn, H.; Yassouridis, A.; Kellner, M.: Anxiolyticlike effects of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks. Archives of General Psychiatry 58, S. 371 - 377 (2001)

Kellner, M.; Wiedemann, K.; Yassouridis, A.; Levengood, R.; Guo, L. S.; Holsboer, F.; Yehuda, R.: Behavioral and endocrine response to cholecystokinin tetrapeptide in patients with posttraumatic stress disorder. Biological Psychiatry 47, S. 107 - 111 (2000)

Neuhaus, O.; Farina, C.; Yassouridis, A.; Wiendl, H.; Then Bergh, F.; Dose, T.; Wekerle, H.; Hohlfeld, R.: Multiple sclerosis: Comparison of copolymer-1-reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells. Proceedings of the National Academy of Sciences USA 97, S. 7452 - 7457 (2000)

Uhr, M.; Steckler, T.; Yassouridis, A.; Holsboer, F.: Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to Mdr 1 a p-glycoprotein gene disruption. Neuropsychopharmacology 22, S. 380 - 387 (2000)

Wetter, T. C.; Collado-Seidel, V.; Pollmächer, T.; Yassouridis, A.; Trenkwalder, C.: Sleep and periodic leg movement patterns in drug-free patients with Parkinson's disease and multiple system atrophy. Sleep 23, S. 361 - 367 (2000)

Winkelmann, J.; Wetter, T. C.; Collado-Seidel, V.; Gasser, T.; Dichgans, M.; Yassouridis, A.; Trenkwalder, C.: Clinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patients. Sleep 23, S. 597 - 602 (2000)

Kümpfel, T.; Then Bergh, F.; Friess, E.; Uhr, M.; Yassouridis, A.; Trenkwalder, C.; Holsboer, F.: Dehydroepiandrosterone response to the adrenocorticotropin test and the combined dexamethasone and corticotropin-releasing hormone test in patients with multiple sclerosis. Neuroendocrinology 70, S. 431 - 438 (1999)

Stein, A.; Yassouridis, A.; Szopko, C.; Helmke, K.; Stein, C.: Intraarticular morphine versus dexamethasone in painful chronic arthritis. Pain 83, S. 525 - 532 (1999)